{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:06:33Z","timestamp":1795147593772,"version":"4.10.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402209"],"award-info":[{"award-number":["82402209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271936"],"award-info":[{"award-number":["82271936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202090"],"award-info":[{"award-number":["82202090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271268"],"award-info":[{"award-number":["82271268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371190"],"award-info":[{"award-number":["82371190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H180002"],"award-info":[{"award-number":["LQ24H180002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY24H090007"],"award-info":[{"award-number":["LY24H090007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02113"],"award-info":[{"award-number":["2025C02113"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01886-5","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:27:57Z","timestamp":1763404077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Real\u2014world application of lecanemab in early\u2014stage alzheimer's disease: a single\u2014center prospective cohort analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Jia","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingze","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"18","key":"1886_CR1","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","volume":"97","author":"L Antolini","year":"2021","unstructured":"Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology. 2021;97(18):e1809\u201322. https:\/\/doi.org\/10.1212\/WNL.0000000000012778.","journal-title":"Neurology"},{"issue":"1","key":"1886_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/jnnp-2014-309493","volume":"87","author":"HM Arrighi","year":"2016","unstructured":"Arrighi HM, Barakos J, Barkhof F, Tampieri D, Jack C, Melan\u00e7on D, et al. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer\u2019s disease treated with bapineuzumab: A historical, prospective secondary analysis. J Neurol Neurosurg Psychiatry. 2016;87(1):106\u201312. https:\/\/doi.org\/10.1136\/jnnp-2014-309493.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1886_CR3","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3174\/ajnr.A3500","volume":"34","author":"J Barakos","year":"2013","unstructured":"Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, et al. MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol. 2013;34(10):1958\u201365. https:\/\/doi.org\/10.3174\/ajnr.A3500.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1886_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3(1):1. https:\/\/doi.org\/10.1186\/alzrt59.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"1886_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100160","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Katayama S, Lee J-H, Lee J-Y, Nakagawa M, Torii K, et al. Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2025;12(5):100160. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100160.","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"1886_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, et al. Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2023;10(3):362\u201377. https:\/\/doi.org\/10.14283\/jpad.2023.30.","journal-title":"J Prev Alzheimers Dis"},{"issue":"21","key":"1886_CR7","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1212\/WNL.0000000000005550","volume":"90","author":"JL Cummings","year":"2018","unstructured":"Cummings JL, Cohen S, van Dyck CH, Brody M, Curtis C, Cho W, et al. ABBY: a phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. Neurology. 2018;90(21):e1889\u201397. https:\/\/doi.org\/10.1212\/WNL.0000000000005550.","journal-title":"Neurology"},{"key":"1886_CR8","unstructured":"FDA Approves New Maintenance Dosing for Lecanemab to Treat Early-Stage Alzheimer Disease. (n.d.). Retrieved February 23, 2025, from https:\/\/www.ajmc.com\/view\/fda-approves-new-maintenance-dosing-for-lecanemab-to-treat-early-stage-alzheimer-disease"},{"issue":"11","key":"1886_CR9","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146(11):4414\u201324. https:\/\/doi.org\/10.1093\/brain\/awad188.","journal-title":"Brain"},{"issue":"1","key":"1886_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13195-024-01507-7","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, et al. Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16(1):159. https:\/\/doi.org\/10.1186\/s13195-024-01507-7.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1886_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01441-8","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, et al. Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimers Res Ther. 2024;16(1):105. https:\/\/doi.org\/10.1186\/s13195-024-01441-8.","journal-title":"Alzheimers Res Ther"},{"key":"1886_CR12","unstructured":"Kane, M. (2012). Lecanemab Therapy and APOE Genotype. In V. M. Pratt, S. A. Scott, M. Pirmohamed, B. Esquivel, B. L. Kattman, & A. J. Malheiro (Eds.), Medical Genetics Summaries. National Center for Biotechnology Information (US). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK605938\/"},{"issue":"8","key":"1886_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0572-y","volume":"15","author":"HS Kirshner","year":"2015","unstructured":"Kirshner HS, Bradshaw M. The Inflammatory Form of Cerebral Amyloid Angiopathy or \u201cCerebral Amyloid Angiopathy-Related Inflammation\u201d (CAARI). Curr Neurol Neurosci Rep. 2015;15(8):54. https:\/\/doi.org\/10.1007\/s11910-015-0572-y.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1886_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00453-4","volume":"16","author":"Y Levites","year":"2021","unstructured":"Levites Y, Funk C, Wang X, Chakrabarty P, McFarland KN, Bramblett B, et al. Modulating innate immune activation states impacts the efficacy of specific A\u03b2 immunotherapy. Mol Neurodegener. 2021;16(1):32. https:\/\/doi.org\/10.1186\/s13024-021-00453-4.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1886_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol. 2007;20(1):29\u201333. https:\/\/doi.org\/10.1177\/0891988706297086.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"12","key":"1886_CR16","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","volume":"14","author":"M Navitsky","year":"2018","unstructured":"Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, et al. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the centiloid scale. Alzheimers Dement. 2018;14(12):1565\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.1353.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1886_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0303-8467(91)90004-9","volume":"93","author":"TH Ng","year":"1991","unstructured":"Ng TH, Leung SY, Wong MP. Cerebral amyloid angiopathy in Chinese: incidence and significance. Clin Neurol Neurosurg. 1991;93(1):19\u201323. https:\/\/doi.org\/10.1016\/0303-8467(91)90004-9.","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"1886_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.1232","volume":"82","author":"M Paczynski","year":"2025","unstructured":"Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D, et al. Lecanemab treatment in a specialty memory clinic. JAMA Neurol. 2025;e251232. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1232.","journal-title":"JAMA Neurol"},{"issue":"12","key":"1886_CR19","doi-asserted-by":"publisher","first-page":"9060","DOI":"10.1007\/s00330-021-08227-8","volume":"31","author":"HY Park","year":"2021","unstructured":"Park HY, Park CR, Suh CH, Shim WH, Kim SJ. Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer\u2019s disease: a systematic review and meta-analysis. Eur Radiol. 2021;31(12):9060\u201372. https:\/\/doi.org\/10.1007\/s00330-021-08227-8.","journal-title":"Eur Radiol"},{"issue":"20","key":"1886_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003613","volume":"95","author":"C Salvarani","year":"2016","unstructured":"Salvarani C, Morris JM, Giannini C, Brown RD, Christianson T, Hunder GG. Imaging findings of cerebral amyloid angiopathy, A\u03b2-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience. Medicine (Baltimore). 2016;95(20):e3613. https:\/\/doi.org\/10.1097\/MD.0000000000003613.","journal-title":"Medicine (Baltimore)"},{"issue":"10284","key":"1886_CR21","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, Strooper BD, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"issue":"6","key":"1886_CR22","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.14283\/jpad.2024.159","volume":"11","author":"LBE Shields","year":"2024","unstructured":"Shields LBE, Hust H, Cooley SD, Cooper GE, Hart RN, Dennis BC, et al. Initial experience with Lecanemab and lessons learned in 71 patients in a regional medical center. J Prev Alzheimers Dis. 2024;11(6):1549\u201362. https:\/\/doi.org\/10.14283\/jpad.2024.159.","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"1886_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.14283\/jpad.2024.139","volume":"11","author":"Z Shirzadi","year":"2024","unstructured":"Shirzadi Z, Schultz AP, Properzi M, Yaari R, Yau W-YW, Brickman AM, et al. Greater white matter hyperintensity volume is associated with the number of microhemorrhages in preclinical Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2024;11(4):869\u201373. https:\/\/doi.org\/10.14283\/jpad.2024.139.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"1886_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg L, Johannesson M, Nygren P, Laudon H, Eriksson F, Osswald G, et al. Lecanemab, aducanumab, and gantenerumab\u2014binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease. Neurotherapeutics. 2023;20(1):195\u2013206. https:\/\/doi.org\/10.1007\/s13311-022-01308-6.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1886_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association research roundtable workgroup. Alzheimers Dement. 2011;7(4):367\u201385. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1886_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11(3):241\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(12)70015-7.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1886_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2015","unstructured":"Tucker S, M\u00f6ller C, Tegerstedt K, Lord A, Laudon H, Sj\u00f6dahl J, et al. The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimers Dis. 2015;43(2):575\u201388. https:\/\/doi.org\/10.3233\/JAD-140741.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1886_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"1886_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.862369","volume":"13","author":"CG Withington","year":"2022","unstructured":"Withington CG, Turner RS. Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer\u2019s disease. Front Neurol. 2022;13:862369. https:\/\/doi.org\/10.3389\/fneur.2022.862369.","journal-title":"Front Neurol"},{"key":"1886_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117037","volume":"416","author":"Y Yakushiji","year":"2020","unstructured":"Yakushiji Y, Tanaka J, Wilson D, Charidimou A, Noguchi T, Kawashima M, et al. Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West: comparison between single hospital centres in Japan and the United Kingdom. J Neurol Sci. 2020;416:117037. https:\/\/doi.org\/10.1016\/j.jns.2020.117037.","journal-title":"J Neurol Sci"},{"issue":"16","key":"1886_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70068","volume":"45","author":"B Yang","year":"2024","unstructured":"Yang B, Earnest T, Kumar S, Kothapalli D, Benzinger T, Gordon B, et al. Evaluation of ComBat harmonization for reducing across-tracer differences in regional amyloid PET analyses. Hum Brain Mapp. 2024;45(16):e70068. https:\/\/doi.org\/10.1002\/hbm.70068.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"1886_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12967-024-05248-x","volume":"22","author":"LX Yi","year":"2024","unstructured":"Yi LX, Tan EK, Zhou ZD. Passive immunotherapy for Alzheimer\u2019s disease: challenges & future directions. J Transl Med. 2024;22(1):430. https:\/\/doi.org\/10.1186\/s12967-024-05248-x.","journal-title":"J Transl Med"},{"issue":"2","key":"1886_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12910-x","volume":"272","author":"M Zavarella","year":"2025","unstructured":"Zavarella M, Cecchetti G, Rugarli G, Ghirelli A, Bottale I, Orlandi F, et al. Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases. J Neurol. 2025;272(2):168. https:\/\/doi.org\/10.1007\/s00415-025-12910-x.","journal-title":"J Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01886-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:27:59Z","timestamp":1763404079000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01886-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practice (GCP) and the Declaration of Helsinki. The protocol, consent form, and other relevant documentation were approved by the Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (Approval Number: 2024\u20131391). All participants voluntarily took part in the study and signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declaration and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}